Akebia Therapeutics (NasdaqCM:AKBA) FY Conference November 10, 2025 03:00 PM ET Speaker1Okay. All right, great. All right, thanks, thanks everyone. Thanks for joining us again for the Guggenheim Healthcare Innovation Conference. Next up in this room, pleased to have Akebia Therapeutics, an interesting story in the kidney space that we've been following for some time. I'm following them on for those of you who don't know, one of the biopharma analysts here at Guggenheim, joined on the stage by John Butler, t ...